Vir Biotechnology, Inc. VIR Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s net income?
- Vir Biotechnology, Inc. (VIR) reported net income of -$125.7M in Q1 2026.
- How has Vir Biotechnology, Inc.'s net income changed year-over-year?
- Vir Biotechnology, Inc.'s net income decreased by 3.9% year-over-year, from -$120.97M to -$125.7M.
- What is the long-term trend for Vir Biotechnology, Inc.'s net income?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s net income has grown at a -6.1% compound annual growth rate (CAGR), from $528.58M to -$437.99M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.